Wanbury balance sheet

As of Mar 2026

Total assets: ₹518cr+25.1% on Mar 2025
Shareholders' equity: ₹144cr+143.7% on Mar 2025
Total debt: ₹215cr+24.4% on Mar 2025
Cash and investments: ₹1.6cr−61.6% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	227	190	149	152
	25.4	5.4	3.0	1.6
	0.0	10.7	0.0	0.0
	2.7	0.2	0.3	0.1
	0.0	0.0	17.5	—
	0.0	0.0	0.0	0.0
	4.0	4.0	6.9	4.2
	4.0	4.1	6.9	4.2
	14.2	7.0	5.5	5.5
	6.3	3.4	1.9	16.8
	279	220	184	180
	50.6	37.7	36.0	22.0
	0.0	0.1	0.0	0.0
	143	114	89.4	68.0
	1.6	4.1	3.4	1.5
	6.0	8.8	2.5	2.4
	2.7	2.1	0.9	0.9
	154	129	96.3	72.7
	34.3	26.5	27.0	25.8
	239	193	159	121
	0.0	0.0	—	2.0
	518	414	343	302
Equity
	34.9	32.8	32.7	32.7
	110	26.5	−4.8	−40.0
	144	59.3	27.9	−7.3
	144	59.3	27.9	−7.3
Liabilities
	147	160	82.0	0.0
	2.4	1.5	3.9	—
	150	162	85.9	0.0
	20.4	17.5	15.5	13.9
	2.2	0.8	—	2.4
	172	180	101	16.3
	68.3	12.9	28.0	64.1
	107	138	0.0	148
	3.5	6.1	171	53.8
	179	157	199	266
	4.7	2.6	3.0	2.7
	—	0.0	—	1.5
	17.2	14.6	12.0	23.1
	201	175	214	293
	373	355	316	310
	518	414	343	302
Trade payables — MSME split
	6.8	4.0	—	—
	100	134	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

WANBURY₹174.16

Wanbury Limited

· Pharma & Health

₹ CrorePeersAHCL ANUHPHR BAJAJHCARE THEMISMED ZIMLAB LINCOLN SIGACHI VALIANTLABMcap ₹609 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	151.5	149.0	189.7	226.5	226.5
+ Capital Work-in-Progress	1.6	3.0	5.4	25.4	25.4
+ Goodwill	0.0	0.0	10.7	0.0	0.0
+ Other Intangibles	0.1	0.3	0.2	2.7	2.7
+ Intangibles under Development	—	17.5	0.0	0.0	0.0
+ Non-current Investments	0.0	0.0	0.0	0.0	0.0
+ Other Non-current Financial Assets	4.2	6.9	4.0	4.0	4.0
Non-current Financial Assets	4.2	6.9	4.1	4.0	4.0
+ Deferred Tax Assets	5.5	5.5	7.0	14.2	14.2
+ Other Non-current Assets	16.8	1.9	3.4	6.3	6.3
Total Non-current Assets	179.7	184.2	220.5	279.1	279.1
Current Assets
+ Inventories	22.0	36.0	37.7	50.6	50.6
+ Current Investments	0.0	0.0	0.1	0.0	0.0
+ Trade Receivables	68.0	89.4	114.2	143.3	143.3
+ Cash & Cash Equivalents	1.5	3.4	4.1	1.6	1.6
+ Other Bank Balances	2.4	2.5	8.8	6.0	6.0
+ Other Current Financial Assets	0.9	0.9	2.1	2.7	2.7
Current Financial Assets	72.7	96.3	129.2	153.6	153.6
+ Other Current Assets	25.8	27.0	26.5	34.3	34.3
Total Current Assets	120.5	159.3	193.4	238.6	238.6
+ Assets Held for Sale	2.0	—	0.0	0.0	0.0
Total Assets	302.2	343.5	413.9	517.7	517.7
Equity
+ Equity Share Capital	32.7	32.7	32.8	34.9	34.9
+ Other Equity / Reserves	-40.0	-4.8	26.5	109.5	109.5
Equity — Owners of Parent	-7.3	27.9	59.3	144.5	144.5
Total Equity	-7.3	27.9	59.3	144.5	144.5
Liabilities
+ Borrowings — Non-current	0.0	82.0	160.3	147.2	147.2
+ Other Non-current Financial Liab	—	3.9	1.5	2.4	2.4
Non-current Financial Liabilities	0.0	85.9	161.8	149.5	149.5
+ Provisions — Non-current	13.9	15.5	17.5	20.4	20.4
+ Other Non-current Liabilities	2.4	—	0.8	2.2	2.2
Non-current Liabilities	16.3	101.4	180.0	172.2	172.2
+ Borrowings — Current	64.1	28.0	12.9	68.3	68.3
+ Trade Payables	148.0	0.0	138.5	107.2	107.2
+ Other Current Financial Liab	53.8	171.1	6.1	3.5	3.5
Current Financial Liabilities	265.9	199.1	157.5	179.1	179.1
+ Provisions — Current	2.7	3.0	2.6	4.7	4.7
+ Current Tax Liabilities	1.5	—	0.0	—	—
+ Other Current Liabilities	23.1	12.0	14.6	17.2	17.2
Current Liabilities	293.2	214.1	174.6	201.0	201.0
Total Liabilities	309.5	315.6	354.6	373.2	373.2
Total Equity & Liabilities	302.2	343.5	413.9	517.7	517.7
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	4.0	6.8	6.8
+ Dues to Other Creditors — Current	—	—	134.5	100.5	100.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.